Publications by authors named "John Mattila"

Claim this Profile
P
PROPERMAB: an integrative framework for prediction of antibody developability using machine learning.
Bian Li, Shukun Luo, Wenhua Wang, Jiahui Xu, Dingjiang Liu, John Mattila

MAbs· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of ionic strength for X-MuLV inactivation by low pH treatment for monoclonal antibody purification.
Jena Daya, Valerie Cusick, John Mattila

Biotechnol Bioeng· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Speed and need: twin development challenges in rapid response for a SARS-CoV-2 antibody cocktail.
Aimee Lehman, Virginia A Muñiz, Ryan Chaney, Joseph Pimentel, John Mattila

Curr Opin Biotechnol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Identification of the Specific Causes of Polysorbate 20 Degradation in Monoclonal Antibody Formulations Containing Multiple Lipases.
Sisi Zhang, Caterina Riccardi, Douglas Kamen, James Reilly, John Mattila

Pharm Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host cell protein profiling of commercial therapeutic protein drugs as a benchmark for monoclonal antibody-based therapeutic protein development.
Rosalynn Molden, Mengqi Hu, Sook Yen E, Diana Saggese, James Reilly, John Mattila

MAbs· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of the specific causes of polysorbate 20 degradation in monoclonal antibody formulations containing multiple lipases.
Sisi Zhang, Caterina Riccardi, Douglas Kamen, James Reilly, John Mattila

Pharm Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Putative Phospholipase B-Like 2 is Not Responsible for Polysorbate Degradation in Monoclonal Antibody Drug Products.
Sisi Zhang, Hui Xiao, Michael Goren, Darya Burakov, Gang Chen, John Mattila

J Pharm Sci· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective Evaluation of Cycled Resin in Viral Clearance Studies-A Multiple Company Collaboration.
John Mattila, Sherrie Curtis, Yenny Webb-Vargas, Eileen Wilson, Olga Galperina

PDA J Pharm Sci Technol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum for John Mattila, Mike Clark, Shengjiang Liu, et al.: "Retrospective Evaluation of Low-pH Viral Inactivation and Viral Filtration Data from a Multiple Company Collaboration".
John Mattila, Mike Clark, Shengjiang Liu, John Pieracci, Thomas R Gervais

PDA J Pharm Sci Technol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective Evaluation of Low-pH Viral Inactivation and Viral Filtration Data from a Multiple Company Collaboration.
John Mattila, Mike Clark, Shengjiang Liu, John Pieracci, Thomas R Gervais

PDA J Pharm Sci Technol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity.
Andrew D Tustian, Christine Endicott, Benjamin Adams, John Mattila, Hanne Bak

MAbs· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis